These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25870373)

  • 1. Breast cancer risk reduction therapy: the low-hanging fruit.
    Bevers TB
    J Natl Compr Canc Netw; 2015 Apr; 13(4):376-8. PubMed ID: 25870373
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast Cancer Risk-Reducing Medications.
    Graham D; DiNome ML; Ganz PA
    JAMA; 2020 Jul; 324(3):310. PubMed ID: 32692388
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventive therapy for breast cancer: a consensus statement.
    Cuzick J; DeCensi A; Arun B; Brown PH; Castiglione M; Dunn B; Forbes JF; Glaus A; Howell A; von Minckwitz G; Vogel V; Zwierzina H
    Lancet Oncol; 2011 May; 12(5):496-503. PubMed ID: 21441069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts in breast cancer chemoprevention.
    Chlebowski RT
    Pol Arch Med Wewn; 2014; 124(4):191-9. PubMed ID: 24618912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of endocrine therapy in breast cancer.
    Ingle JN
    J Hum Genet; 2013 Jun; 58(6):306-12. PubMed ID: 23635953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advancement in endocrine therapy for breast cancer].
    Yang MT; Lian ZQ
    Ai Zheng; 2007 Apr; 26(4):440-4. PubMed ID: 17430670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current developments in hormonal therapy of breast cancer.
    Buzdar AU
    Clin Breast Cancer; 2004 Sep; 5 Suppl 1():S4-5. PubMed ID: 15347432
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
    de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
    Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.
    Bender CM; Sereika SM; Brufsky AM; Ryan CM; Vogel VG; Rastogi P; Cohen SM; Casillo FE; Berga SL
    Menopause; 2007; 14(6):995-8. PubMed ID: 17898668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones 'R' us.
    Sledge GW
    Clin Breast Cancer; 2002 Jan; 2(4):251. PubMed ID: 11899355
    [No Abstract]   [Full Text] [Related]  

  • 11. Current role of endocrine therapy in the management of breast cancer.
    Robertson JF
    Breast Cancer; 2002; 9(4):276-81. PubMed ID: 12459706
    [No Abstract]   [Full Text] [Related]  

  • 12. Aromatase inhibitors: current indications and future prospects for treatment of postmenopausal breast cancer.
    Arora A; Potter JF
    J Am Geriatr Soc; 2004 Apr; 52(4):611-6. PubMed ID: 15066080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
    Wu K; Brown P
    J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.
    Vogel VG
    Curr Drug Targets; 2011 Dec; 12(13):1874-87. PubMed ID: 21158712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Tseng CW; Wong JB
    JAMA; 2019 Sep; 322(9):857-867. PubMed ID: 31479144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Fu R; Zakher B; Pappas M; McDonagh M
    JAMA; 2019 Sep; 322(9):868-886. PubMed ID: 31479143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When to start an aromatase inhibitor: now or later?
    Doughty JC
    J Surg Oncol; 2011 Jun; 103(7):730-8. PubMed ID: 21360530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on breast cancer prevention trials.
    Wickerham DL; Fourchotte V
    Int J Gynecol Cancer; 2006; 16 Suppl 2():498-501. PubMed ID: 17010056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medications for Primary Prevention of Breast Cancer.
    Shieh Y; Tice JA
    JAMA; 2020 Jul; 324(3):291-292. PubMed ID: 32692377
    [No Abstract]   [Full Text] [Related]  

  • 20. Exemestane for primary prevention of breast cancer in postmenopausal women.
    Zhang Y; Simondsen K; Kolesar JM
    Am J Health Syst Pharm; 2012 Aug; 69(16):1384-8. PubMed ID: 22855103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.